Accelerating Therapy Uptake with Behavior‑Led HCP Segmentation

Pharma’s commercial environment is shifting faster than traditional segmentation can adapt. As pressures rise and clinical pathways grow more complex, many established brands experience a loss of momentum. This is not because their therapies have lost value, but rather because visibility into real‑world behavior has faded. Enter: behavior-led HCP segmentation.

Traditionally used static segmentation models were built on specialty, geography, or prescribing history. They can’t reveal where opportunities have shifted or why some physicians hesitate.

Today, meaningful growth depends on evolving from broad categorization to behavior‑led precision. McKinsey captures why this matters:

“Organizations that leverage customer behavioral insights outperform peers by 85% in sales growth. And that's more than 25% in gross margin.”

For brands navigating crowded or competitive markets, understanding what HCPs do, not just who they are, is essential to restoring clarity and accelerating therapy uptake.

Where Traditional Segmentation Falls Short

Traditional segmentation overlooks the real friction points that impact prescribing. These include: diagnostic readiness, confidence in testing, and timing within the clinical journey. Without insight into these dynamics, brands risk engaging physicians at the wrong time. Moments when they cannot act, slowing progress and obscuring where true opportunity lies.

As highlighted in our webinar series:

“Doctors not realizing the clinical significance of biomarkers simply do not order the test. Or sometimes they order the test and don’t act on the results.”

Optimize Your Physician Engagement Strategy: Data-Driven HCP Engagement in Precision Medicine

2024. Gosia Leitch, VP of Engagement Solutions

Behavior‑Led HCP Segmentation Restores Actionable Clarity

Behavior‑led HCP segmentation focuses on real‑world patterns. What and when physicians test. How confident they are in interpreting results. And, of course, how quickly they adopt new practices.

Crucially, it aligns engagement to clinical timing. As Gosia Leitch explains:

“We match biomarker‑positive patients to their treating physician and deliver laser‑focused digital education within 24 hours.”

Optimize Your Physician Engagement Strategy: Data-Driven HCP Engagement in Precision Medicine

2024. Gosia Leitch, VP of Engagement Solutions

This approach reconnects brands with the exact moments where behavior can shift. And this helps rebuild confidence and re‑establish relevance in competitive spaces.

Multimodal Segmentation Reveals Hidden Opportunity

Behavior alone is only part of the picture. The strongest commercial strategies now combine behavioral signals with diagnostic and biomarker insights. This helps to build a multimodal view of the market.

Gunjan Aggarwal summarizes the need for this connected approach:

“We need a connected data strategy - not just first‑party digital data, but lab data and real‑world evidence.”

Data-Driven Targeting in HCP Education: Engaging Physicians within the Critical Treatment Window

2025. Gunjan Aggarwal, Executive Director, Novartis

This reveals:

• Missed patients hidden in testing patterns
• Physicians who are ready to act but lack timely guidance
• How a multi-modal approach to data enables precise HCP segmentation
• System friction delaying adoption

This level of clarity is essential for brands looking to regain traction in their category.

How Behavior‑Led HCP Segmentation Drives Faster Uptake

When segmentation aligns behavioral signals, diagnostic events, and clinical timing, brands see:

• Greater relevance, because outreach matches real‑time clinical need
• Faster prescribing decisions, grounded in up‑to‑date diagnostic understanding
• More efficient resource use, by focusing on eligible HCP segmentation
• Fewer missed patients, as triggers connect testing directly to action

This shift from broad outreach to precision timing is what helps brands regain lost momentum and drive measurable impact.

Turning Insight Into Action: Why Timing Matters Most

Even the most advanced segmentation and diagnostic insight only create impact when paired with timely activation. Many barriers that slow adoption can’t be solved by increased frequency. They need trusted, relevant education delivered when the physician is making decisions.

This is where many brands face the final gap. They see the opportunity but aren't able to act quickly enough to influence it.

Physician Engage enables brands to close this final activation gap. It turns real‑time diagnostic triggers into tailored, clinically relevant education. This content can be delivered within the treatment decision window. It provides the speed, specificity, and credibility needed. And the HCP segmentation helps support the right physicians, at the right time.

With Physician Engage, teams can:

• Activate prescribers within 24 hours of a verified diagnostic trigger
• Deliver expert‑curated, clinically trusted content aligned to real-world events
• Reduce hesitation by filling knowledge gaps at the point of decision
• Drive therapy starts with targeted outreach proven to outperform industry benchmarks
• Achieve higher engagement, with open rates reaching up to 43% and click‑through rates far above standard omnichannel norms

Physician Engage connects diagnostic insight to timely education. This ensures brands don’t just identify the opportunity; they act on it before it slips away.

This is how brands move beyond static targeting and into a more responsive, data‑driven model. One that brings focus, timing, and impact back into their commercial strategy.